Table 1 Clinical characteristics of study subjects
Item | Healthy control | Hemodialysis patient | P value |
|---|---|---|---|
N | 85 | 134 | |
Ferritin (ng/ml) | 165.4 ± 110.0 | 453.9 ± 325.5 | <0.001 |
SI (μg/dl) | 91.3 ± 36.6 | 61.2 ± 23.0 | <0.001 |
TSAT (%) | 29.5 ± 17.3 | 25.4 ± 10.9 | 0.031 |
TIBC (μg/dl) | 335.4 ± 62.9 | 252.6 ± 59.1 | <0.001 |
i-PTH (pg/ml) | 26.4 ± 12.9 | 445.7 ± 502.8 | <0.001 |
Hematocrit (%) | 40.0 ± 3.9 | 32.9 ± 2.5 | <0.001 |
Albumin (g/dl) | 4.56 ± 0.27 | 3.97 ± 0.36 | <0.001 |
Phosphate (mg/dl) | 3.59 ± 0.42 | 5.39 ± 1.48 | <0.001 |
Calcium (mg/dl) | 9.18 ± 0.37 | 9.33 ± 0.87 | 0.136 |
Gas6 (ng/ml) | 6.65 ± 1.75 | 14.16 ± 3.28 | <0.001 |
IL-6 (pg/ml) | 1.15 ± 1.89 | 2.35 ± 2.05 | <0.001 |
hs-CRP (mg/l) | 0.9 ± 0.9 | 6.7 ± 14.0 | 0.002 |
RBC fragility test (% of NaCl) | 0.426 ± 0.034 | 0.414 ± 0.049 | 0.075 |